• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于网络药理学和肠道菌群分析探究四君子汤改善哮喘小鼠模型气道炎症的机制

Integrated Network Pharmacology and Gut Microbiota Analysis to Explore the Mechanism of Sijunzi Decoction Involved in Alleviating Airway Inflammation in a Mouse Model of Asthma.

作者信息

Jia Wenqing, Xu Chengling, Zhao Tong, Fan Qiuyang, Qiao Bo, Wu Yueying, Yuan Jiali, Chen Jing

机构信息

School of Basic Medical Science, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.

School of Chinese Medical Science, Hunan University of Chinese Medicine, Changsha, Hunan, China.

出版信息

Evid Based Complement Alternat Med. 2023 Jan 3;2023:1130893. doi: 10.1155/2023/1130893. eCollection 2023.

DOI:10.1155/2023/1130893
PMID:36636604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9831717/
Abstract

BACKGROUND

Asthma is a chronic inflammatory disease of the airways with recurrent attacks, which seriously affects the patients' quality of life and even threatens their lives. The disease can even threaten the lives of patients. Sijunzi decoction (SJZD), a classical Chinese medicine formula with a long history of administration, is a basic formula used for the treatment of asthma and demonstrates remarkable efficacy. However, the underlying mechanism has not been elucidated.

MATERIALS AND METHODS

We aimed to integrate network pharmacology and intestinal flora sequencing analysis to study the mechanism of SJZD in the treatment of allergic asthmatic mice. The active compounds of SJZD and their asthma-related targets were predicted by various databases. We performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses to identify potentially relevant pathways for target genes. Furthermore, the active compound-target and target-signaling pathway network maps were constructed by using Cytoscape 3.8.2. These results were combined with those of the intestinal flora sequencing analysis to study the influence of SJZD on airway inflammation in allergic asthmatic mice.

RESULT

We obtained 137 active compounds from SJZD and associated them with 1445 asthma-related targets acquired from the databases. A total of 109 common targets were identified. We visualized active compound-target and target-signaling pathway network maps. The pathological analysis and inflammation score results suggested that SJZD could alleviate airway inflammation in asthmatic mice. Sequencing analysis of intestinal flora showed that SJZD could increase the relevant abundance of beneficial bacterial genus and maintain the balance of the intestinal flora. The core toll-like receptor (TLR) signaling pathway was identified based on network pharmacology analysis, and the important role TLRs play in intestinal flora and organismal immunity was also recognized. The analysis of the correlation between environmental factors and intestinal flora revealed that beneficial bacterial genera were negatively correlated with TLR2 and positively correlated with the TLR7 expression. Furthermore, they were positively correlated with IFN- and IL-10 levels and negatively correlated with IL-4 and IL-17 levels.

CONCLUSION

SJZD alleviated the airway inflammation state in asthmatic mice. The findings suggest that increasing the relevant abundance of beneficial intestinal bacteria in mice with asthma, regulating intestinal flora, interfering with the level of TLR2 and TLR7 expression to adjust the secretion of inflammatory factors, and alleviating asthmatic airway inflammation may be the possible mechanism involved in the treatment of asthma by SJZD, providing a basis for further studies on SJZD.

摘要

背景

哮喘是一种气道慢性炎症性疾病,反复发作,严重影响患者生活质量,甚至威胁生命。四君子汤(SJZD)是一种应用历史悠久的经典中药方剂,是治疗哮喘的基础方剂,疗效显著。然而,其潜在机制尚未阐明。

材料与方法

我们旨在整合网络药理学和肠道菌群测序分析,以研究SJZD治疗过敏性哮喘小鼠的机制。通过各种数据库预测SJZD的活性成分及其哮喘相关靶点。我们进行了基因本体论(GO)和京都基因与基因组百科全书(KEGG)分析,以确定靶基因潜在的相关途径。此外,使用Cytoscape 3.8.2构建活性成分-靶点和靶点-信号通路网络图谱。将这些结果与肠道菌群测序分析结果相结合,研究SJZD对过敏性哮喘小鼠气道炎症的影响。

结果

我们从SJZD中获得了137种活性成分,并将它们与从数据库中获取的1445个哮喘相关靶点相关联。共鉴定出109个共同靶点。我们可视化了活性成分-靶点和靶点-信号通路网络图谱。病理分析和炎症评分结果表明,SJZD可减轻哮喘小鼠的气道炎症。肠道菌群测序分析表明,SJZD可增加有益菌属的相关丰度,维持肠道菌群平衡。基于网络药理学分析确定了核心Toll样受体(TLR)信号通路,并认识到TLR在肠道菌群和机体免疫中的重要作用。环境因素与肠道菌群相关性分析表明,有益菌属与TLR2呈负相关,与TLR7表达呈正相关。此外,它们与IFN-和IL-10水平呈正相关,与IL-4和IL-17水平呈负相关。

结论

SJZD减轻了哮喘小鼠的气道炎症状态。研究结果表明,增加哮喘小鼠肠道有益菌的相关丰度、调节肠道菌群、干扰TLR2和TLR7表达水平以调节炎症因子分泌、减轻哮喘气道炎症可能是SJZD治疗哮喘的潜在机制,为进一步研究SJZD提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/d5ad8abcf6f4/ECAM2023-1130893.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/4ed166bad428/ECAM2023-1130893.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/4d712c261520/ECAM2023-1130893.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/a3055e673a40/ECAM2023-1130893.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/9cf80dd72ece/ECAM2023-1130893.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/3097456ff0a9/ECAM2023-1130893.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/44795935db65/ECAM2023-1130893.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/45c05592d8d9/ECAM2023-1130893.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/b14fed7d491a/ECAM2023-1130893.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/32b80f8f9bf1/ECAM2023-1130893.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/cd45eebb15d9/ECAM2023-1130893.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/76016ab1d9b3/ECAM2023-1130893.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/d5ad8abcf6f4/ECAM2023-1130893.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/4ed166bad428/ECAM2023-1130893.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/4d712c261520/ECAM2023-1130893.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/a3055e673a40/ECAM2023-1130893.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/9cf80dd72ece/ECAM2023-1130893.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/3097456ff0a9/ECAM2023-1130893.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/44795935db65/ECAM2023-1130893.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/45c05592d8d9/ECAM2023-1130893.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/b14fed7d491a/ECAM2023-1130893.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/32b80f8f9bf1/ECAM2023-1130893.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/cd45eebb15d9/ECAM2023-1130893.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/76016ab1d9b3/ECAM2023-1130893.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/9831717/d5ad8abcf6f4/ECAM2023-1130893.012.jpg

相似文献

1
Integrated Network Pharmacology and Gut Microbiota Analysis to Explore the Mechanism of Sijunzi Decoction Involved in Alleviating Airway Inflammation in a Mouse Model of Asthma.基于网络药理学和肠道菌群分析探究四君子汤改善哮喘小鼠模型气道炎症的机制
Evid Based Complement Alternat Med. 2023 Jan 3;2023:1130893. doi: 10.1155/2023/1130893. eCollection 2023.
2
Integration of LC-LTQ-Orbitrap-MS and Network Pharmacology to Analyze the Active Components of Sijunzi Decoction and their Mechanism of Action Against Cytotoxicity-associated Premature Ovarian Insufficiency.基于 LC-LTQ-Orbitrap-MS 与网络药理学分析四君子汤治疗细胞毒性相关卵巢早衰的活性成分及其作用机制
Comb Chem High Throughput Screen. 2023;26(14):2437-2451. doi: 10.2174/1386207326666230303094247.
3
Ginseng-Containing Sijunzi Decoction Ameliorates Ulcerative Colitis by Orchestrating Gut Homeostasis in Microbial Modulation and Intestinal Barrier Integrity.含人参的四君子汤通过调节微生物和肠道屏障完整性来改善溃疡性结肠炎的肠道稳态。
Am J Chin Med. 2023;51(3):677-699. doi: 10.1142/S0192415X23500325. Epub 2023 Mar 8.
4
A Network Pharmacology Approach for Uncovering the Antitumor Effects and Potential Mechanisms of the Sijunzi Decoction for the Treatment of Gastric Cancer.基于网络药理学方法揭示四君子汤治疗胃癌的抗肿瘤作用及潜在机制
Evid Based Complement Alternat Med. 2022 Apr 12;2022:9364313. doi: 10.1155/2022/9364313. eCollection 2022.
5
A mechanism of Sijunzi decoction on improving intestinal injury with spleen deficiency syndrome and the rationality of its compatibility.四君子汤改善脾虚证肠道损伤的机制及其配伍合理性
J Ethnopharmacol. 2023 Apr 24;306:116088. doi: 10.1016/j.jep.2022.116088. Epub 2023 Jan 14.
6
Multi-omics integrated analyses indicated that non-polysaccharides of Sijunzi decoction ameliorated spleen deficiency syndrome via regulating microbiota-gut-metabolites axis and exerted synergistic compatibility.多组学综合分析表明,四君子汤的非多糖成分通过调节微生物群-肠道-代谢物轴发挥协同作用来改善脾虚证。
J Ethnopharmacol. 2024 Sep 15;331:118276. doi: 10.1016/j.jep.2024.118276. Epub 2024 May 1.
7
Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation.基于网络药理学和实验验证的四君子汤治疗结直肠癌的机制。
J Ethnopharmacol. 2023 Feb 10;302(Pt A):115876. doi: 10.1016/j.jep.2022.115876. Epub 2022 Nov 5.
8
Differential effect of polysaccharide and nonpolysaccharide components in Sijunzi decoction on spleen deficiency syndrome and their mechanisms.四君子汤多糖和非多糖成分对脾气虚证的差异作用及其机制。
Phytomedicine. 2021 Dec;93:153790. doi: 10.1016/j.phymed.2021.153790. Epub 2021 Oct 8.
9
The mechanism of Sanzi Yangqin decoction for asthma treatment based on network pharmacology and experimental verification.三子养亲汤治疗哮喘的作用机制基于网络药理学和实验验证。
BMC Complement Med Ther. 2023 Dec 13;23(1):452. doi: 10.1186/s12906-023-04272-6.
10
[Mechanism and experimental verification of Sijunzi Decoction in treatment of ulcerative colitis based on network pharmacology].基于网络药理学的四君子汤治疗溃疡性结肠炎的作用机制及实验验证
Zhongguo Zhong Yao Za Zhi. 2020 Nov;45(22):5362-5372. doi: 10.19540/j.cnki.cjcmm.20200810.405.

引用本文的文献

1
Mechanisms of (Thunb.) Franch. Extract in Asthma Therapy: Oxidative Stress, Inflammation, and Gut Microbiota.(羌活) Franch. 提取物在哮喘治疗中的作用机制:氧化应激、炎症和肠道微生物群
Biology (Basel). 2025 Jun 19;14(6):731. doi: 10.3390/biology14060731.
2
Traditional Chinese medicine to improve immune imbalance of asthma: focus on the adjustment of gut microbiota.中医改善哮喘免疫失衡:聚焦肠道微生物群的调节
Front Microbiol. 2024 Oct 1;15:1409128. doi: 10.3389/fmicb.2024.1409128. eCollection 2024.
3
Antibiotic administration aggravates asthma by disrupting gut microbiota and the intestinal mucosal barrier in an asthma mouse model.

本文引用的文献

1
Microbiota in a long survival discourse with the human host.与人类宿主长期共存的微生物组。
Arch Microbiol. 2022 Nov 28;205(1):5. doi: 10.1007/s00203-022-03342-6.
2
Ephedra sinica polysaccharide alleviates airway inflammations of mouse asthma-like induced by PM2.5 and ovalbumin via the regulation of gut microbiota and short chain fatty acid.麻黄多糖通过调节肠道微生物群和短链脂肪酸减轻PM2.5和卵清蛋白诱导的小鼠哮喘样气道炎症。
J Pharm Pharmacol. 2022 Nov 25;74(12):1784-1796. doi: 10.1093/jpp/rgac078.
3
The Changes in Bacterial Microbiome Associated with Immune Disorder in Allergic Respiratory Disease.
在哮喘小鼠模型中,抗生素给药通过破坏肠道微生物群和肠道黏膜屏障加重哮喘。
Exp Ther Med. 2024 Feb 21;27(4):157. doi: 10.3892/etm.2024.12445. eCollection 2024 Apr.
变应性呼吸道疾病中与免疫紊乱相关的细菌微生物组变化
Microorganisms. 2022 Oct 19;10(10):2066. doi: 10.3390/microorganisms10102066.
4
Preclinical evidence for quercetin against inflammatory bowel disease: a meta-analysis and systematic review.槲皮素治疗炎症性肠病的临床前证据:一项荟萃分析和系统评价。
Inflammopharmacology. 2022 Dec;30(6):2035-2050. doi: 10.1007/s10787-022-01079-8. Epub 2022 Oct 13.
5
Ephedrae Herba polysaccharides inhibit the inflammation of ovalbumin induced asthma by regulating Th1/Th2 and Th17/Treg cell immune imbalance.麻黄多糖通过调节 Th1/Th2 和 Th17/Treg 细胞免疫失衡抑制卵清蛋白诱导的哮喘炎症。
Mol Immunol. 2022 Dec;152:14-26. doi: 10.1016/j.molimm.2022.09.009. Epub 2022 Oct 7.
6
The understanding of asthma pathogenesis in the era of precision medicine.精准医学时代对哮喘发病机制的认识。
Allergol Int. 2023 Jan;72(1):3-10. doi: 10.1016/j.alit.2022.09.001. Epub 2022 Oct 1.
7
Lactobacillus delbrueckii UFV-H2b20 increases IFN-γ production and CD39CD73 Treg cell numbers in lungs, and protects mice against experimental allergic asthma.德氏乳杆菌 UFV-H2b20 增加肺部 IFN-γ 的产生和 CD39CD73 Treg 细胞数量,并保护小鼠免受实验性变应性哮喘的影响。
Immunobiology. 2022 Nov;227(6):152284. doi: 10.1016/j.imbio.2022.152284. Epub 2022 Sep 26.
8
Elevated CXCL14 in Induced Sputum Was Associated with Eosinophilic Inflammation and Airway Obstruction in Patients with Asthma.诱导痰中 CXCL14 水平升高与哮喘患者的嗜酸性粒细胞炎症和气道阻塞有关。
Int Arch Allergy Immunol. 2022;183(11):1216-1225. doi: 10.1159/000526367. Epub 2022 Sep 5.
9
The association between early-life gut microbiota and childhood respiratory diseases: a systematic review.生命早期肠道微生物群与儿童呼吸道疾病的关联:系统评价。
Lancet Microbe. 2022 Nov;3(11):e867-e880. doi: 10.1016/S2666-5247(22)00184-7. Epub 2022 Aug 18.
10
Biological Activities Underlying the Therapeutic Effect of Quercetin on Inflammatory Bowel Disease.槲皮素治疗炎症性肠病的疗效基础:生物学活性。
Mediators Inflamm. 2022 Jul 23;2022:5665778. doi: 10.1155/2022/5665778. eCollection 2022.